Macrolide therapy for chronic rhinosinusitis: a meta-analysis.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 23314162.
- Also identified by DOI 10.1177/0194599812470427 and PMC identifier 4104166.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The objective of this study was to systematically review patient-reported outcomes of long-term macrolide therapy, compared with any other treatment, for adults with chronic rhinosinusitis. EMBASE and PubMed databases were searched in October 2011. A total of 1216 citations were screened initially by a single author, 23 full-text manuscripts were evaluated by 2 authors using structured data abstraction forms to assess for inclusion criteria and study quality, and 3 studies were included in the final review. This review finds that 3 prospective clinical studies have evaluated the effect of macrolide therapy for chronic rhinosinusitis. Based on the limited data, there is limited scientific evidence to support the use of long-term macrolide therapy for chronic rhinosinusitis. Further clinical research is needed to determine whether there may be a subgroup effect based on the underlying inflammatory disease process.
Medical subject headings
- Macrolides
- Rhinitis
- Sinusitis